Lutz Uharek

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Nicolaus Kröger, Ernst Holler, Guido Kobbe et al. · Blood · 2009 · 394 citations · Full text

Medicine, Hematology, Immunology +17

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

Peter Dreger, Hartmut Döhner, Matthias Ritgen et al. · Blood · 2010 · 304 citations · Full text

Medicine, Immunology, Oncology +15

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

Ulrich Keilholz, Anne Letsch, Antonia Busse et al. · Blood · 2009 · 300 citations · Full text

Medicine, Immunology, Oncology +16

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

Thomas Schroeder, Elena Rachlis, Gesine Bug et al. · Biology of Blood and Marrow Transplantation · 2014 · 202 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

Maximilian Christopeit, Jürgen Finke, Ulrike Bacher et al. · Journal of Clinical Oncology · 2013 · 173 citations · Full text

Medicine, Hematology, Cell Therapy +15